A daughter’s story: My mother’s keeper
July 4, 2024
Written by Erin, Maureen’s daughter. I’d like you to meet my beautiful…
Read more arrow_forwardNews
Written by Erin, Maureen’s daughter. I’d like you to meet my beautiful…
Read more arrow_forwardThe Albanese Government has today announced that it will provide funding that will enable free access at to the effective drug DFMO for every Australian child and young adult with high-risk neuroblastoma.
Read more arrow_forward
Fiercely independent, 76-year-old Doug has found that learning to accept help –…
Read more arrow_forward
Patricia Curnow remembers looking back at photos with her grandchildren from Christmas…
Read more arrow_forwardRare Cancers Australia (RCA) has welcomed the release of the highly anticipated Senate report into equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancers.
Read more arrow_forwardRare Cancers Australia (RCA) welcomed the Federal Government’s budget announcement this week,…
Read more arrow_forwardPeak cancer body, Rare Cancers Australia, has co-authored a pre-Budget submission of…
Read more arrow_forward
The peak body for rare cancers in Australia welcomes two new members…
Read more arrow_forwardOver the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.
Read more arrow_forwardRare Cancers Australia, and an army of peak cancer organisations, call on the Pharmaceutical Benefits Advisory Committee (PBAC) to expand access to the breakthrough PD-1/PD-L1 inhibitor class of medicines for the more than 3,500 Aussies who would benefit.
Read more arrow_forward